Colony-stimulating factor use in the context of refined risk and benefit assessments.
作者信息
Crawford Jeffrey
机构信息
Division of Medical Oncology, Duke Comprehensive Cancer Center, Durham, North Carolina 27710-0001, USA.
出版信息
Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):9-10.
PMID:16736982
Abstract
摘要
相似文献
1
Colony-stimulating factor use in the context of refined risk and benefit assessments.在精细的风险和效益评估背景下使用集落刺激因子。
Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):9-10.
2
Granulocyte colony-stimulating factors.粒细胞集落刺激因子
Med Lett Drugs Ther. 1991 Jun 28;33(847):61-3.
3
[The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].
Rev Invest Clin. 1996 Jul-Aug;48(4):328.
4
The therapeutic use of hematopoietic growth factors.造血生长因子的治疗用途。
J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):1-6. doi: 10.1016/S0091-6749(98)70185-X.
5
Myeloid growth factors.髓系生长因子
J Natl Compr Canc Netw. 2009 Jan;7(1):64-83. doi: 10.6004/jnccn.2009.0006.
6
A tale of two growth factors.
Pharmacotherapy. 2006 Mar;26(3):443-4; discussion 444. doi: 10.1592/phco.26.3.443.
7
Interactive discussion on chemotherapy-related adverse events.关于化疗相关不良事件的互动讨论
Pharmacotherapy. 2000 Jul;20(7 Pt 2):121S-125S. doi: 10.1592/phco.20.10.121s.35231.
8
Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia.集落刺激因子在预防发热性中性粒细胞减少症患者化疗诱导的实体瘤中的作用
Int J Antimicrob Agents. 1998 Apr;10(1):3-9. doi: 10.1016/s0924-8579(98)00016-8.
9
[Rational therapy with G-CSF and GM-CSF].
Med Klin (Munich). 1994 Aug 15;89(8):429-41.
10
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.
J Am Coll Cardiol. 2005 Nov 1;46(9):1649-50. doi: 10.1016/j.jacc.2005.08.010.
Zotero 插件